Journal Articles

Permanent URI for this collectionhttps://mro.massey.ac.nz/handle/10179/7915

Browse

Author: search.filters.author.Lopez-Villalobos NSubject: search.filters.subject.prevalence

Search Results

Now showing 1 - 2 of 2
  • Thumbnail Image
    Item
    Prevalence of the ABCB1-1Δ gene mutation in a sample of New Zealand Huntaway dogs
    (Informa UK Limited, trading as Taylor & Francis Group, 2023-03-13) Gedye K; Poole-Crowe E; Shepherd M; Wilding A; Parton K; Lopez-Villalobos N; Cave N
    AIMS: To determine the prevalence of the ATP Binding Cassette Subfamily B Member 1-1Δ mutation (ABCB1-1Δ; previously Multidrug Resistance 1 (MDR1) mutation) in a cohort of New Zealand Huntaway dogs. MATERIALS AND METHODS: Samples were opportunistically collected from Huntaway dogs (n = 189) from throughout New Zealand. Buccal swabs were collected from 42 Huntaways from the Wairarapa region and 147 blood samples from Huntaways from the Gisborne, Waikato, Manawatū/Whanganui, Hawkes Bay, Canterbury and Otago regions. DNA was extracted from all samples and tested for the presence of the ABCB1-1Δ allele. RESULTS: Of 189 Huntaway dogs that were tested, two were found to be heterozygous carriers of the ABCB1-1Δ allele and the remaining 187/189 dogs were homozygous for the wild type allele. No dogs homozygous for the mutation were identified. CONCLUSIONS AND CLINICAL RELEVANCE: The results of this study show that the ABCB1-1Δ allele is present in Huntaway dogs. The low prevalence in this convenience sample suggests that the prevalence of this allele in the Huntaway population is likely to be low. We recommend that veterinary clinicians discuss the potential for this mutation in Huntaways with dog owners including the clinical implications for dogs that are homozygous for the mutated allele and the potential for testing for the mutation, as they would do for other known mutations.
  • Thumbnail Image
    Item
    Prevalence and incidence rate of clinical lameness in three New Zealand dairy goat farms
    (Taylor and Francis Group, 2024-01-01) Jaques N; Turner S-A; Vallee E; Heuer C; Deeming L; Lopez-Villalobos N
    Clinical lameness has an impact on animal welfare and profitability in different livestock industries. The objective of this study was to estimate the prevalence and incidence rate of clinical lameness within New Zealand dairy goat farms. Up to 3246 goats on three dairy goat farms were observed 4–5 times over one year. Data on locomotion scores and animal information were collected between June 2019 and June 2020. A 5-point (0–4) locomotion scoring scale was used, where scores 3 and 4 were classified as clinical lameness. The average herd-level prevalence of clinical lameness for farms A, B, and C were 23, 12, and 10%, respectively. The annual incidence rate of clinical lameness for farms A, B, and C were 104, 56, and 55 cases per 100 goat-years, respectively. Lameness appears to be a significant welfare issue, with incidence varying between farms and between goats. Investigating both farm-level and goat-level factors is required to understand the epidemiology of lameness and design evidence-based control and prevention measures. Further investigation should be undertaken to identify variables affecting the goat's odds of becoming clinically lame. This study sets the foundation for future study of lameness in commercial dairy goat farms nationally and internationally.